Evidence map›Paper›PMID 36394784›Full record

ArticleInternational journal of clinical pharmacy2023

Clinical pharmacy services are reimbursed in Germany: challenges of real world implementation remain.

Martin Schulz, Nina Griese-Mammen, Uta Müller

Abstract read
In one paragraph

Article in International journal of clinical pharmacy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Hypertension care: the knowledge and attitudes of the community pharmacists.Journal of pharmaceutical policy and practice · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Martin SchulzInstitute of Pharmacy, Freie Universität Berlin, Kelchstraße 31, 12169, Berlin, Germany. m.schulz@fu-berlin.de.ORCID https://orcid.org/0000-0002-5876-7322
Nina Griese-MammenDepartment of Medicine, ABDA - Federal Union of German Associations of Pharmacists, Heidestr. 7, 10557, Berlin, Germany.ORCID https://orcid.org/0000-0002-8830-9031
Uta MüllerDepartment of Medicine, ABDA - Federal Union of German Associations of Pharmacists, Heidestr. 7, 10557, Berlin, Germany.ORCID https://orcid.org/0000-0003-0969-9084

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the last two decades, community pharmacy has experienced major changes as the role of pharmacists is evolving from a product to a service and a patient focus. As part of this change, new and innovative clinical pharmacy services aimed at improving medicines use and patient outcomes have been designed, both nationally and internationally. Since June 2022, five services are reimbursed by all statutory health insurance funds and private insurance companies in Germany: medication review for patients with polymedication; blood pressure control in hypertension; assuring proper inhalation techniques for patients receiving a new device or a device change; medication review including a follow-up for patients taking oral anticancer drugs or immunosuppressants post-transplantation. Beyond reimbursement, the upscaling and sustainable provision of these professional services are now the main challenges. Implementation research will provide important information for the further development of pharmaceutical care programs.

Indexed as

Community Pharmacy ServicesPharmacy Service, HospitalGermanyHumansMedication Therapy ManagementPharmacistsProfessional RoleCommunity pharmacy servicesMedication reviewMedication therapy managementPharmaceutical servicesPharmacy

Identifiers

PMID36394784
PMCPMC9938802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.